| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Johnson David Michael is a Director at Zentalis Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 12,896 | $51.39 | $662,746.59 | -2.9% | |
| Apr 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Buy | 4,000 | $18.00 | $72,000.00 | +3.6% |